What are the criteria to determine if a woman is a candidate for Hormone Replacement Therapy (HRT) for menopause symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: May 21, 2025 • View editorial policy

From the Guidelines

To determine if someone is a candidate for hormone replacement therapy (HRT) for menopause symptoms, they should consult with a healthcare provider who will evaluate several factors, including severity of symptoms, medical history, and risk factors, as recommended by the USPSTF 1. The evaluation process typically involves assessing the severity of menopause symptoms, such as hot flashes, night sweats, vaginal dryness, mood changes, and sleep disturbances. The provider will also consider the woman's medical history, family history, and risk factors, including age, to determine the best course of treatment.

  • Ideal candidates for HRT typically experience moderate to severe symptoms that impact quality of life, are within 10 years of menopause onset or under age 60, and don't have contraindications, such as history of breast cancer, endometrial cancer, cardiovascular disease, stroke, blood clots, liver disease, or unexplained vaginal bleeding 1.
  • The evaluation usually involves a physical exam, possibly blood tests to confirm menopause status, and discussion of benefits versus risks, with the goal of prescribing the lowest effective dose for the shortest duration needed to manage symptoms 2, 3.
  • HRT options include estrogen-only therapy (for women without a uterus), estrogen plus progestin (for women with a uterus to prevent endometrial cancer), and various delivery methods like pills, patches, gels, or vaginal preparations, with the choice of therapy based on the intersection of a woman's clinical situation, preferences, and values to maximize benefits over harms 1.

From the FDA Drug Label

All women should receive yearly breast examinations by a healthcare provider and perform monthly breast self-examinations. In addition, mammography examinations should be scheduled based on patient age, risk factors and prior mammogram results.

To determine if someone is a candidate for hormone replacement therapy for menopause symptoms, a healthcare provider should evaluate the patient's overall health, including:

  • Breast examination and mammography results
  • Risk factors for breast cancer, ovarian cancer, and other conditions
  • Age and menopausal status However, the provided drug label does not directly answer the question of how to determine if someone is a candidate for hormone replacement therapy. 4

From the Research

Determining Candidacy for Hormone Replacement Therapy

To determine if someone is a candidate for hormone replacement therapy (HRT) for menopause symptoms, several factors must be considered.

  • Symptom Severity: Recently menopausal women with moderate or severe symptoms are appropriate candidates for HRT, as stated in 5.
  • Time Since Menopause: The timing of HRT initiation is crucial, with more favorable effects on coronary heart disease and all-cause mortality in younger women (close proximity to menopause) than in women more than a decade past menopause, as indicated in 5.
  • Comorbidities: The presence of contraindications or other major comorbidities must be assessed, as they may affect the risk-benefit ratio of HRT, according to 5.
  • Uterus Status: Women with an intact uterus require a progestogen in addition to estrogen to reduce the risk of endometrial hyperplasia and carcinoma, as discussed in 6 and 7.
  • Type and Route of Administration: The type and route of administration of HRT can impact its effectiveness and risk profile, with different regimens having varying effects on endometrial hyperplasia, irregular bleeding, and adherence to therapy, as reported in 6 and 7.

Patient-Specific Considerations

Patient-specific considerations, such as age, time since menopause, and comorbidity status, should be weighed when prescribing HRT, as emphasized in 5 and 8.

  • Age: Younger women (close proximity to menopause) may have a more favorable risk-benefit ratio for HRT, as suggested in 5.
  • Comorbidity Status: Women with certain comorbidities, such as cardiovascular disease or breast cancer, may require careful consideration of the risks and benefits of HRT, as discussed in 8 and 9.
  • Individual Symptoms and Needs: The decision to prescribe HRT should be based on individual symptoms and needs, taking into account the potential benefits and risks of treatment, as stated in 9.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.